ICMR task force meets to discuss inclusion of Pfizer’s Paxlovid for Covid treatment https://ift.tt/ldATMhW

Pfizer’s Paxlovid contains Nirmatrelvir, which inhibits a SARS-CoV-2 protein to stop the virus from replicating, and Ritonavir, which slows down Nirmatrelvir’s breakdown to help it remain in the body for a longer period at higher concentrations. It’s administered as three tablets—two of Nirmatrelvir and one of Ritonavir—taken together orally twice daily for five days (30 tablets in total).

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/HUiDBjq